Surface disinfectants are the synthetic substances that healthcare environmental services departments use for cleaning and disinfecting surfaces, such as counterparts, floors and walls. They kill and resist microorganisms, such as fungi, viruses, and bacteria. The sales of surface disinfectants have remarkably increased in the last few years, thanks to improved awareness about the importance of proper health and hygiene.

An ESOMAR-certified market research and consulting firm in a study has forecast the trend to continue, enabling the surface disinfectants market to surpass $6.8 billion in 2021. The fundamental factor boosting the surface disinfectants sales is the increasing occurrences of infections around the world, according to a press release from Future Market Insights.

Direction from International associations such as the Center for Disease Control and Prevention (CDC), World Health Organization (WHO), and International Federation of Infection Control (IFIC) often encourage disinfection to contain the spread of viruses, which will bode well for the market.

High level disinfectants have emerged as top-selling products in the market, which hospitals will continue as the leading end user. The demand from hospitals segment is forecast to surge at a compound annual growth rate above 6.4 percent. Other key takeaways from the study include:

• The surface disinfectants market will register growth at 8.8 percent compound annual growth rate. Sales are expected to surge amid COVID-19 outbreak.
• The United States will spearhead growth in North America, accounting for maximum sales of surface disinfectants. Increasing healthcare spending will seal the dominance of the United States.
• Presence of a sophisticated healthcare infrastructure catapults the United Kingdom as a lucrative market for surface disinfectants.
• Germany and France will continue exhibiting high demand, thanks to increasing focus on health and wellness.
• Post COVID-19, sales will rise in China, Japan, and South Korea.